In an opinion piece published in today s New York Times, Dr. Richard J. Ablin addresses the serious problems with prostate cancer screening. Dr. Ablin discovered the prostate-specific antigen, or PSA, in 1970 (although widespread PSA screening didn t become routine until the 1990s) and it
In November - or as it is now more commonly being referred to Movember - millions of men commit to grow moustaches to raise awareness of men s health issues, such as
A new, large cohort analysis from the prospective Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial, indicates that
Prostate-specific antigen (PSA) screening is a commonly ordered test, despite it s being a highly debated public health practice, and despite recent recommendations which continue to condemn the screening strategy. However, despite the US Preventive Services Task Force s (USPSTF) and other experts recommendations against routine
A new type of genetic analysis of prostate cancers from biopsies seems to give a better assessment of prognosis than the standard methods. What implications might this have for the future of prostate cancer prognosis and follow-up?
A recent study from the Harvard School of Public Health suggests vasectomies are associated with an increased risk of advanced or lethal prostate cancer.
Large database study of Medicare patients shows no significant benefit in terms of survival from prostate cancer for those receiving androgen deprivation therapy: bilateral orchiectomy or hormonal anti-androgens.
Cancer meeting reports improvements in survival for men with advanced prostate cancer and young women after breast cancer excision.
Prostate cancer (PRCA) is really (at least) two different diseases. The most common form sometimes called the kitty cat form, is by far the most common, and the least harmful. Most men who have this type will eventually die from something other than the cancer. On the other hand, the aggressive tiger form is much less common, but has a far different outcome.
The BPA-cancer link is making headlines again. This time, researchers from the University of Illinois at Chicago claim that
No medical organization recommends the prostate-specific antigen test for older men, and yet many primary care doctors continue to administer it even to those over age 75. Why?